Interaction of Chemotherapy and Biological Response Modifiers in the Treatment of Melanoma-Reference-Cited by-同舟云学术

Interaction of Chemotherapy and Biological Response Modifiers in the Treatment of Melanoma

Published:1996 Issue: Volume: Page:357-380
ISSN:0927-3042
Container-title:Drug Resistance
language:
Short-container-title:

Author:

Anderson Clay M.,Buzaid Antonio C.,Grimm Elizabeth A.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4613-1267-3_15.pdf

Reference126 articles.

1. Wingo P, Tong T, Bolden S (1995) Cancer Statistics, 1995. CA Cancer J Clin 45:8–30.

2. Karavodin L, Golub S (1984) Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor ratios in melanoma patients during interferon treatment. Nat Immun Cell Growth Regul 3:193–202.

3. Hersey P, MacDonald M, Hall C, Spurling A, Edwards A, Coates A, McCarthy W (1986) Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma. Cancer 57:1666–1674.

4. Creagan E, Ahmann D, Frytak S (1986) Phase II trials of recombinant leukocyte alpha interferon in disseminated malignant melanoma: Results in 96 patients. Cancer Treat Rep 70:619–624.

5. Legha S (1989) Current therapy for malignant melanoma. Semin Oncol 16:34–44.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation;International Immunopharmacology;2006-05

2. Hepatoprotective Effect of 20(S)-Ginsenosides Rg3 and Its Metabolite 20(S)-Ginsenoside Rh2 on tert-Butyl Hydroperoxide-Induced Liver Injury;Biological and Pharmaceutical Bulletin;2005